PETMED EXPRESS, INC. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
PETMED EXPRESS, INC. (PETS) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $0 for the 12-month period ending 2026-03-31, per its 10-K filed 2026-06-02.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-06-02
- PETMED EXPRESS, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2024-06-30 was $2.22M, a 0.00% change year-over-year.
- PETMED EXPRESS, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2024-03-31 was $0.00.
- PETMED EXPRESS, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2023-12-31 was $2.22M.
- PETMED EXPRESS, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2023-09-30 was $0.00.
- PETMED EXPRESS, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2026 was $0.00.
- PETMED EXPRESS, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- PETMED EXPRESS, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $2.22M.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month as first filed |
|---|---|---|---|---|---|
| 2026-03-31 | $0.00 10-K · filed 2026-06-02 | ||||
| 2025-03-31 | $0.00 10-K · filed 2026-06-02 | $2.22M 10-K · filed 2025-10-14 | |||
| 2024-06-30 | $2.22M 10-Q · filed 2024-08-07 | $2.22M derived: sum of 2 quarters · filed 2026-06-02 | $4.44M derived: sum of 3 quarters · filed 2026-06-02 | $4.44M derived: sum of 4 quarters · filed 2026-06-02 | |
| 2024-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-02 | $2.22M derived: sum of 2 quarters · filed 2026-06-02 | $2.22M derived: sum of 3 quarters · filed 2026-06-02 | $2.22M 10-K · filed 2026-06-02 | |
| 2023-12-31 | $2.22M 10-Q · filed 2024-04-15 | $2.22M derived: sum of 2 quarters · filed 2024-04-15 | $2.22M 10-Q · filed 2024-04-15 | ||
| 2023-09-30 | $0.00 derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-04-15 | $2.22M 10-Q/A · filed 2024-04-15 | |||
| 2023-06-30 | $2.22M 10-Q/A · filed 2024-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVS HEALTH Corp (CVS) | United States | $108.783B | 27.06 |